In-vitro Activity of Avermectins against Mycobacterium ulcerans

Mycobacterium ulcerans causes Buruli ulcer (BU), a debilitating infection of subcutaneous tissue. There is a WHO-recommended antibiotic treatment requiring an 8-week course of streptomycin and rifampicin. This regime has revolutionized the treatment of BU but there are problems that include reliance...

Descripción completa

Detalles Bibliográficos
Autores principales: Omansen, Till F., Porter, Jessica L., Johnson, Paul D. R., van der Werf, Tjip S., Stienstra, Ymkje, Stinear, Timothy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351077/
https://www.ncbi.nlm.nih.gov/pubmed/25742173
http://dx.doi.org/10.1371/journal.pntd.0003549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351077/
https://www.ncbi.nlm.nih.gov/pubmed/25742173
http://dx.doi.org/10.1371/journal.pntd.0003549

Ejemplares similares